Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sixth Wave Innovations Inc SIXWF

Sixth Wave Innovations Inc. is a Canada-based nanotechnology company with patented technologies. The Company is focused on the extraction and detection of target substances at the molecular level using specialized molecularly imprinted polymers (MIPs). The Company’s product brands include AMIPs, IXOS and Affinity. The IXOS is a line of extraction polymers formulated for deployment in the gold... see more

GREY:SIXWF - Post Discussion

Sixth Wave Innovations Inc > Filing of Preliminary Short Form Base Shelf Prospectus
View:
Post by Betteryear2 on Jan 27, 2022 6:15pm

Filing of Preliminary Short Form Base Shelf Prospectus

Halifax, Nova Scotia--(Newsfile Corp. - January 27, 2022) - Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) ("Sixth Wave" or the "Company") is pleased to announce today that it has filed a preliminary short form base shelf prospectus (the "Prospectus").

The Prospectus was filed with the securities regulatory authorities in each of the Provinces and Territories of Canada. The Prospectus was filed to provide the Company with financial flexibility and efficient access to Canadian capital markets to pursue its growth initiatives. A copy of the Prospectus is available under the Company's profile on SEDAR at www.sedar.com.

Once a receipt for the final Prospectus is received from the applicable securities regulators, the final Prospectus will be valid for a 25-month period during which time the Company will be permitted to offer up to $25 million of common shares, warrants, subscription receipts, debt securities, or any combination thereof, including in the form of units (collectively, the "Securities").

If any Securities are offered under the Prospectus, the terms of any such Securities and the intended use of the net proceeds resulting from such offering would be established at the time of any offering and would be described in a prospectus supplement filed with the applicable Canadian securities regulatory authorities at the time of such offering and would be made available by the Company.

This press release does not constitute an offer to sell or the solicitation of an offer to buy Securities, nor will there be any sale of the Securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under securities laws of any such jurisdiction.

The Canadian Securities Exchange has not reviewed, approved, or disapproved the content of this news release.

About Sixth Wave

Sixth Wave is a nanotechnology company with patented technologies that focus on extraction and detection of target substances at the molecular level using highly specialized Molecularly Imprinted Polymers (MIPs). The Company is in the process of a commercial rollout of its Affinity™ cannabinoid purification system, as well as, IXOS®, a line of extraction polymers for the gold mining industry. The Company is in the development stages of a rapid diagnostic test for viruses under the Accelerated MIPs (AMIPs™) label.

Sixth Wave can design, develop and commercialize MIP solutions across a broad spectrum of industries. The company is focused on nanotechnology architectures that are highly relevant for the detection and separation of viruses, biogenic amines, and other pathogens, for which the Company has products at various stages of development.

www.sixthwave.com.

 

https://www.newsfilecorp.com/release/111909

 
Comment by beenthere on Jan 27, 2022 8:07pm
Well that answers a lot of questions for me! So much for your conspiracy theory! lol
Comment by throwaway11 on Jan 27, 2022 8:51pm
since you're clearly more savvy than all of us, please explain. You think the company is being aggressively sold down because someone estimated the incoming application to authorize more shares? This would reinforce what I have been saying, not diminish it.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities